Dykan Jeff 的 Form 4/A 修正申報
修正Lifeward Ltd.（LFWD），2022/6/30 申報
- 申報編號
- 0001062993-22-015670
- 申報時間
- 2022/6/30
- 交易日
- 2022/6/7-6/8
- 申報延遲
- 23 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2022/6/9
這份申報列了 2 筆非衍生性交易。公開市場買進合計 $2.54 萬。交易後 23 天申報。
這份修正申報取代了 0001062993-22-014549（2022/6/9 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Dykan JeffCIK 0001661229 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
This amendment is being filed to correct the number of shares directly and indirectly held by the reporting person. On July 7, 2020, the reporting person reported the acquisition of 10,948 Ordinary Shares underlying restricted stock units, which were granted to the reporting person on July 2, 2020 pursuant to the issuer's equity compensation plan. Such Ordinary Shares should have been reported as directly held, but due to an administrative error, such shares were mistakenly reported as indirectly held. See also footnote 6.
- F2
Represents Ordinary Shares purchased in the open market on June 7, 2022.
- F3
The range in prices for the transaction reported on this line was $1.00 to $1.01. The average weighted price was $1.00. The reporting person will provide, upon request by the Securities and Exchange Commission ("SEC"), the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within such range.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents Ordinary Shares purchased in the open market on June 8, 2022.
- F5
The range in prices for the transaction reported on this line was $1.03 to $1.04. The average weighted price was $1.04. The reporting person will provide, upon request by the SEC, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within such range.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Based on filings made with the SEC, consists of 40,707 Ordinary Shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 Ordinary Shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 55,874 shares of the Company.